Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to PET ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Systemic amyloidosis.Curr Opin Pharmacol. 2006; 6: 214-220
- Diagnosis and management of the cardiac amyloidoses.Circulation. 2005; 112: 2047-2060
- Amyloidosis: pathogenesis and new therapeutic options.J Clin Oncol. 2011; 29: 1924-1933
- Transthyretin: a review from a structural perspective.Cell Mol Life Sci. 2001; 58: 1491-1521
- Mechanisms of amyloidogenesis.Nat Struct Biol. 2000; 7: 824-826
- Cardiac amyloidosis.Clin Med (Lond). 2018; 18: s30-s35
- Screening for transthyretin amyloid cardiomyopathy in everyday practice.JACC Heart Failure. 2019; 7: 709-716
- Transthyretin (ttr) cardiac amyloidosis.Circulation. 2012; 126: 1286-1300
- Improved outcomes for newly diagnosed al amyloidosis between 2000 and 2014: cracking the glass ceiling of early death.Blood. 2017; 129: 2111-2119
- Relative apical sparing of myocardial longitudinal strain is explained by regional differences in total amyloid mass rather than the proportion of amyloid deposits.JACC Cardiovasc Imaging. 2019; 12: 1165-1173
- Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers.J Am Coll Cardiol. 2012; 60: 1067-1076
- Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts.Circulation. 2001; 104: 1594-1597
- Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish.Am J Physiol Heart Circ Physiol. 2013; 305: H95-H103
- Circulating amyloidogenic free light chains and serum n-terminal natriuretic peptide type b decrease simultaneously in association with improvement of survival in al.Blood. 2006; 107: 3854-3858
- Do troponin and b-natriuretic peptide detect cardiomyopathy in transthyretin amyloidosis?.J Intern Med. 2008; 263: 294-301
- Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types.Circulation. 2009; 120: 1203-1212
- Cardiovascular magnetic resonance for amyloidosis.Heart Fail Rev. 2015; 20: 133-144
- Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens.Blood. 2009; 114: 4957-4959
- Varying levels of small microcalcifications and macrophages in attr and al cardiac amyloidosis: implications for utilizing nuclear medicine studies to subtype amyloidosis.Cardiovasc Pathol. 2016; 25: 413-417
- Early identification of amyloid heart disease by technetium-99m-pyrophosphate scintigraphy: a study with familial amyloid polyneuropathy.Am Heart J. 1987; 113: 654-662
- 99m)tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.Circ Cardiovasc Imaging. 2013; 6: 195-201
- Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mtc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.J Am Coll Cardiol. 2005; 46: 1076-1084
- Usefulness of (99m)tc-hmdp scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis.Amyloid. 2015; 22: 210-220
- Accuracy of 99mtc-hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis.J Nucl Cardiol. 2019; 26: 497-504
- Nonbiopsy diagnosis of cardiac transthyretin amyloidosis.Circulation. 2016; 133: 2404-2412
- Fluorescence microscopy with thioflavine-t in the diagnosis of amyloid.J Pathol Bacteriol. 1963; 86: 437-442
- Uncharged thioflavin-t derivatives bind to amyloid-beta protein with high affinity and readily enter the brain.Life Sci. 2001; 69: 1471-1484
- Molecular mechanism of thioflavin-t binding to amyloid fibrils.Biochim Biophys Acta. 2010; 1804: 1405-1412
- Mechanism of thioflavin t binding to amyloid fibrils.J Struct Biol. 2005; 151: 229-238
- Imaging brain amyloid in alzheimer's disease with pittsburgh compound-b.Ann Neurol. 2004; 55: 306-319
- Cardiac amyloid imaging with 18f-florbetaben pet: a pilot study.J Nucl Med. 2016; 57: 1733-1739
- Use of florbetapir-pet for imaging beta-amyloid pathology.JAMA. 2011; 305: 275-283
- In vivo visualization of amyloid deposits in the heart with 11c-pib and pet.J Nucl Med. 2013; 54: 213-220
- 18f-florbetapir binds specifically to myocardial light chain and transthyretin amyloid deposits: autoradiography study.Circ Cardiovasc Imaging. 2015; 8 (10.1161/CIRCIMAGING.114.002954 e002954)
- Imaging cardiac amyloidosis: a pilot study using (1)(8)f-florbetapir positron emission tomography.Eur J Nucl Med Mol Imaging. 2014; 41: 1652-1662
- Amyloid pet imaging in cardiac amyloidosis: a pilot study using (18)f-flutemetamol positron emission tomography.Ann Nucl Med. 2019; 33: 624-628
- Improved quantification of cardiac amyloid burden in systemic light chain amyloidosis: redefining early disease?.JACC Cardiovasc Imaging. 2020; 13: 1325-1336
Article info
Publication history
Published online: February 12, 2021
Footnotes
Funding Source: Supported in part by the Institute for Translational Medicine and Therapeutics (ITMAT:Philadelphia, PA, USA) Transdisciplinary Program in Translational Medicine and Therapeutics.
Identification
Copyright
© 2020 Elsevier Inc. All rights reserved.
